Questing for an optimal, universal viral agent for oncolytic virotherapy.

about

Mathematical model for radial expansion and conflation of intratumoral infectious centers predicts curative oncolytic virotherapy parameters.Perfusion Pressure Is a Critical Determinant of the Intratumoral Extravasation of Oncolytic Viruses

P2860

Q34989252-F70C56E3-70CC-424F-A64B-43423DD67857 Q36756897-85F33DCC-375A-4141-9397-B668ABECA446

P2860

Questing for an optimal, universal viral agent for oncolytic virotherapy.

Item

http://www.wikidata.org/entity/Q51470376

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Questing for an optimal, universal viral agent for oncolytic virotherapy.

@en

Questing for an optimal, universal viral agent for oncolytic virotherapy.

@nl

type

Item

label

Questing for an optimal, universal viral agent for oncolytic virotherapy.

@en

Questing for an optimal, universal viral agent for oncolytic virotherapy.

@nl

prefLabel

Questing for an optimal, universal viral agent for oncolytic virotherapy.

@en

Questing for an optimal, universal viral agent for oncolytic virotherapy.

@nl

P1476

Questing for an optimal, universal viral agent for oncolytic virotherapy.

@en

P2093

Martins ML

http://www.w3.org/2001/XMLSchema#string

Paiva LR

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer cell death enhances the penetration and efficacy of oncolytic herpes simplex virus in tumors

Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide

Tumor-vascular interactions and tumor dormancy

Mechanisms of viral membrane fusion and its inhibition

Towards predictive computational models of oncolytic virus therapy: basis for experimental validation and model selection.

Dynamics of multiple myeloma tumor therapy with a recombinant measles virus.

Current issues and future directions of oncolytic adenoviruses.

Mathematical modeling of herpes simplex virus distribution in solid tumors: implications for cancer gene therapy.

Replicative adenoviruses for cancer therapy.

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells.

P304

041918

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1103/PHYSREVE.84.041918

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

4 Pt 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Silvio C Ferreira

P577

2011-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22181186

http://www.w3.org/2001/XMLSchema#string

P818

1109.3614

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

Questing for an optimal, universal viral agent for oncolytic virotherapy.

about

P2860

P2860

Questing for an optimal, universal viral agent for oncolytic virotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P818

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P818

P921